MINANEWS > MINATEC’s newsletter

Number 57: December 2019

Clinatec’s innovative neuroprosthesis and exoskeleton protected by eighteen patents

Clinatec’s innovative neuroprosthesis and exoskeleton protected by eighteen patents

Clinatec’s Brain-Computer Interface (BCI) project was recently featured in The Lancet Neurology* and has appeared in the media worldwide. This groundbreaking project shows just how powerful the Clinatec model—medical doctors and technology experts working side-by-side under one roof—is at driving innovation.   The...

Number 56: October 2019

BHT2: MINATEC Entreprises exceeds targets

BHT2: MINATEC Entreprises exceeds targets

Construction on the BHT2 building was completed last spring, and startup Prophesee moved its R&D department into a 154 sq. m space at the end of September. Prophesee’s R&D team will be working on the integration of its neuromorphic vision technology into...

Number 55: June 2019

Aledia invests in own R&D facility

Number 54: April 2019

AIDS vaccine: Lipidots® open the door to a novel approach

AIDS vaccine: Lipidots® open the door to a novel approach

Researchers from Leti, CEA Sciences, and INSERM injected Lipidots® (lipid-based nanoparticles) containing the p24 protein of the Human Immunodeficiency Virus (HIV) into an animal model and obtained a robust and complete immune response. Lipidots® were created by Leti and CNRS in...

Number 53: February 2019

300 mm: Leti brings state-of-the-art technology to industry

300 mm: Leti brings state-of-the-art technology to industry

Thanks to Nano 2022 initiative funding, Leti will complete installation of its first wave of 30 pieces of 300 mm microelectronics equipment in 2019. The equipment will expand Leti’s technological capabilities, positioning the institute to address tomorrow’s innovations. The Nano 2022 initiative,...

More information
X